𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Proteomic analysis of human lysosomes: Application to monocytic and breast cancer cells

✍ Scribed by Agnès Journet; Agnès Chapel; Sylvie Kieffer; Florence Roux; Jérôme Garin

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
308 KB
Volume
2
Category
Article
ISSN
1615-9853

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel nuclear matrix protein HET binds t
Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells
✍ Steffi Oesterreich; Adrian V. Lee; Toby M. Sullivan; Shanti K. Samuel; James R. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Since the small heat shock protein hsp27 enhances both growth and drug resistance in breast cancer cells, and is a bad prognostic factor in certain subsets of breast cancer patients, we have characterized the transcriptional regulation of hsp27, with the long-term goal of targeting its expression cl

Systematic analysis of clinically applic
Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells
✍ María L. Lamana; José C. Segovia; Guillermo Guenechea; Juan A. Bueren 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 1 views

Background The transduction of human peripheral blood T cells with retroviral vectors constitutes an attractive approach for the correction of a number of genetic diseases. In this study we have conducted a systematic analysis of the relevance of a large number of parameters currently considered to

The potent anti-proliferative effect of
The potent anti-proliferative effect of 20-EPI analogues of 1,25 dihydroxyvitamin D3 in human breast-cancer MCF-7 cells is related to promoter selectivity
✍ Christina Mørk Hansen; Carina Danielsson; Carsten Carlberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 458 KB 👁 1 views

The hormone I ,25-dihydroxyvitamin D3 (VD) has a potential use as an anti-tumor agent, but its clinical applications are restricted by its strong calcemic activity. This has led to the development of VD analogues with selectively increased growthinhibitory activity. One of the most potent analogues